- Title: Subtitle
- ORAL TREPROSTINIL TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION PARTICIPANTS IN FREEDOM-EV AND THE FREEDOM-EV OPEN-LABEL EXTENSION STUDY
- Creators
- R. JAMES WhiteJOANNA PEPKE-ZABAVIJAY P BALASUBRAMANIANJean M ElwingMADELON MC VONKStephan H RosenkranzLINDA M CadaretSANDEEP SahayZAIXIN YULOUIS HoldstockC.Q. DengSCOTT SeamanMEREDITH BroderickCARMINE DV VIZZA
- Resource Type
- Abstract
- Publication Details
- Chest, Vol.162(4), pp.A2301-A2303
- DOI
- 10.1016/j.chest.2022.08.1909
- ISSN
- 0012-3692
- eISSN
- 1931-3543
- Language
- English
- Date published
- 10/2022
- Academic Unit
- Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984361569102771
Abstract
ORAL TREPROSTINIL TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION PARTICIPANTS IN FREEDOM-EV AND THE FREEDOM-EV OPEN-LABEL EXTENSION STUDY
Chest, Vol.162(4), pp.A2301-A2303
10/2022
DOI: 10.1016/j.chest.2022.08.1909
Details
Metrics
11 Record Views